A doença secundária do pénis é uma situação clínica frequentemente associada a doença disseminada e as localizações mais comuns são os órgãos genito-urinários. O prognóstico é mau e as opções de tratamento incluem: penectomia; excisão local; radioterapia; quimioterapia; terapêutica de suporte. Apesar das várias terapêuticas existentes, nenhuma na literatura é apontada como superior às restantes. Os autores documentam o caso de um doente de 66 anos com metástase da glande peniana em contexto de adenocarcinoma do recto, diagnosticada dois anos após o tratamento da doença primária. O doente foi submetido a tratamento paliativo com radio-quimioterapia e permanece assintomático e livre de doença após um ano de seguimento. O follow-up apertado dos doentes com neoplasia do recto é mandatório. A radio-quimioterapia é uma abordagem válida, com bom controlo da doença e melhoria sintomática. Palavras-chave: Metástases; Neoplasias do Pénis/secundária; Neoplasias do Recto; Radioterapia.
BACKGROUND
The metastatic involvement of the penis is a rare condition, with less than 400 cases reported in literature. 1 In 64% of the cases, genito-urinary organs (prostate and bladder) are the primary sites of origin.
2
A penile nodule or mass, priapism, penile pain, urinary retention and hematuria are frequent presenting symptoms, even though no pathognomonic clinical features exist. 3, 4 The authors present a case of metastasis to the glans penis secondary to a rectal adenocarcinoma, diagnosed 2 years after abdominoperineal resection.
CASE PRESENTATION
A 63-year-old man with a personal history of tobacco consumption (40 pack-year), total prostatectomy for benign prostatic hypertrophy, presented with diarrhea, rectorrhagia, and weigh loss (7 kg in 7 months). Colonoscopy showed an ulcerated lesion of the distal rectum and histologic evaluation of the tumor biopsy revealed a moderately differentiated adenocarcinoma. After abdominopelvic computed tomography (CT) and pelvic magnetic resonance imaging (MRI), the rectal adenocarcinoma was staged as a cT3N+M0, according to the TNM Classification of Malignant Tumours (TNM). 5 Neoadjuvant treatment with 3D conformal external radiotherapy (pelvic total dose of 50.4 Gy in 28 fractions, four-field technique) and concomitant capecitabine (850 mg/m 2 , twice a day, 5 days/week), was performed from July to August 2011. In October 2011, the patient underwent abdominoperineal resection and pathological examination was consistent with ypT3N1. There were several post-operative complications, including surgical repair of a prostatic-cutaneous fistula. No adjuvant chemotherapy was performed.
A skin lesion on the glans was noted on January 2013, evolving with progressive growth and spontaneous bleeding. Clinically, an erythematous ill-defined infiltrating plaque with an irregular surface and hard consistency occupying the right half of the glans was observed (Fig. 1 ). Histology and immunohistochemistry confirmed the clinical hypothesis of a metastasis to the glans penis of an adenocarcinoma with colorectal origin (Fig.s 2 and 3) .
The patient underwent 3D conformal external radiotherapy of the penile lesion (total dose of 30 Gy in 10 fractions, one direct field technique with electrons) (Fig. 4 ) with concomitant capecitabine (825 mg/m2, twice a day, 5 days/week). There were no reported side effects and complete response of penile lesion occurred.
Chest, abdominal and pelvic post-treatment reevaluation CT scans were unremarkable. The patient remains asymptomatic and disease-free at 1 year follow-up (Fig. 5) .
DISCUSSION
In spite of the rich vascularization and extensive communication between the penis and the neighboring organs, penile metastatic lesions are rare. route, arterial spread, arterial extension, direct extension and surgical instrumentation. Retrograde venous flow from the pudendal venous system onto the dorsal venous system of the penis, which provides routes for easy transportation of malignant cells, is considered the most likely mechanism. 2, 6 Eberth reported the first case of secondary penile malignancy in 1870 and almost 400 cases were documented ever since.
1 New data have recently revealed prostate and bladder as the most common primary sites. Other primary locations are rectum, kidney, colon and testes.
2
Penile involvement is usually associated with disseminated disease and generally predicts a poor prognosis. 7, 8 Nevertheless, some authors have reported long survival cases. In 1961, Abeshouse 9 documented two patients surviving over nine years after their cancer diagnosis -in one case, the metastasis to the glans penis was treated with low dose rate brachytherapy and, in the other one, with surgical excision and adjuvant external radiotherapy.
Most cases present clinically with a nodule/mass or induration of penis; in 40% of patients, priapism is also pointed as a prominent feature.
A suspected penile metastasis should be differentiated from primary penile cancer, chancre, primary syphilis, chancroid, condylomata acuminata, non-tumorous priapism, Peyronie's disease, tuberculosis and other inflammatory diseases. 2, 7 For the exact diagnosis, an incisional or fine-needle aspiration biopsy for pathological examination is required. Ultrasonography, CT, MRI and positron emission tomography are useful noninvasive methods for the metastatic disease evaluation and restaging. 6 The choice of treatment is greatly influenced by the performance status and primary cancer stage, but frequently has a palliative intention. Treatment options include penectomy, local surgical excision, radiation therapy, chemotherapy and supportive therapy. Neither of these therapeutic options lead to superior treatment outcomes in the literature. 4 
TAKE HOME MESSAGES
-Penile metastases are rare, and colorectal cancer is an infrequent primary source.
-A close follow-up of colorectal cancer patients is crucial.
-Biopsy of suspicious lesions is mandatory, especially in infrequent recurrence locations like the glans penis.
-The appropriate treatment depends on the exact histological diagnosis.
-Radiochemotherapy is a feasible and effective therapeutic option for penile metastasis of colorectal origin, avoiding more aggressive surgical approaches.
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